Smallpox vaccine
Showing 1 - 25 of 8,280
Monkeypox Trial in Nigeria (Bavarian Nordic smallpox vaccine, Typhoid VI Polysaccharide Vaccine Injectable Solution)
Not yet recruiting
- Monkeypox
- Bavarian Nordic smallpox vaccine
- Typhoid VI Polysaccharide Vaccine Injectable Solution
-
Abuja, Nigeria
- +7 more
Feb 16, 2023
Smallpox, Monkeypox, Cowpox Trial in Novosibirsk (VAC?6 vaccine - ?nce at a dose of 106 PFU, VAC?6 vaccine - once at a dose of
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine - оnce at a dose of 10⁶ PFU
- +3 more
-
Novosibirsk, Koltsovo, Novosibirsk Region, Russian FederationFederal State Budgetary Healthcare Institution - Medical and San
Feb 28, 2023
Smallpox, Monkeypox, Cowpox Trial in Koltsovo, Novosibirsk (VAC?6 vaccine (107 PFU), VAC?6 vaccine (106 PFU), Live Smallpox
Completed
- Smallpox
- +3 more
- VAC∆6 vaccine (10⁷ PFU)
- +3 more
-
Koltsovo, Novosibirsk Region, Russian Federation
- +1 more
Apr 25, 2023
Safety Surveillance Study of ACAM2000® Vaccinia Vaccine
Completed
- Smallpox
- ACAM2000® smallpox vaccine
-
Twentynine Palms, California
- +3 more
Aug 17, 2022
Monkeypox Virus Infection Trial in Boende (IMVAMUNE)
Active, not recruiting
- Monkeypox Virus Infection
- IMVAMUNE
-
Boende, Tshuapa, Congo, The Democratic Republic of theTshuapa site
May 11, 2022
FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at
Recruiting
- Monkeypox
-
Antwerp, BelgiumInstitute of Tropical Medicine
May 19, 2023
Smallpox Vaccine Adverse Reaction Trial in Winnipeg (Vaccination with ACAM2000)
Completed
- Smallpox Vaccine Adverse Reaction
- Vaccination with ACAM2000
-
Winnipeg, Manitoba, CanadaBio Products Laboratory Ltd (plasma vendor of Emergent BioSoluti
Aug 17, 2021
Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Montréal (Imvamune)
Recruiting
- Non-melanoma Skin Cancer
- +2 more
- Imvamune
-
Montréal, Quebec, CanadaMcGill University Health Centre
Nov 26, 2020
HIV Trial in United States (TBC-3B Vaccine, Smallpox Vaccine)
Completed
- HIV Infections
- TBC-3B Vaccine
- Smallpox Vaccine
-
Saint Louis, Missouri
- +4 more
Oct 27, 2021
Smallpox Trial in Omaha, Columbus (JYNNEOS + TPOXX, JYNNEOS + TPOXX PLACEBO)
Recruiting
- Smallpox
- JYNNEOS + TPOXX
- JYNNEOS + TPOXX PLACEBO
-
Omaha, Nebraska
- +1 more
Jun 30, 2022
Yellow Fever, Yellow Fever Immunisation Trial in Iowa City, Saint Louis (drug, biological, other)
Completed
- Yellow Fever
- Yellow Fever Immunisation
- ISA-720
- +4 more
-
Iowa City, Iowa
- +1 more
Jun 24, 2021
Smallpox Trial in South Miami, Lenexa, Lexington (LF formulation of IMVAMUNE®, FD formulation of IMVAMUNE®)
Completed
- Smallpox
- LF formulation of IMVAMUNE®
- FD formulation of IMVAMUNE®
-
South Miami, Florida
- +2 more
Oct 9, 2020
Smallpox Vaccine Adverse Reaction Trial in Altamonte Springs (ACAM2000)
Completed
- Smallpox Vaccine Adverse Reaction
- ACAM2000
-
Altamonte Springs, FloridaCangene Plasma Resources, Mid-Florida
Mar 16, 2020
Myocarditis After Replication-Deficient Smallpox Immunization
Not yet recruiting
- Myopericarditis
- Small Pox
- JYNNEOS
- (no location specified)
Aug 22, 2022
Monkeypox, Monkey Pox Trial in Amsterdam (Natural course of disease)
Recruiting
- Monkeypox
- Monkey Pox
- Natural course of disease
-
Amsterdam, Noord-Holland, NetherlandsPublic Health Service
Oct 4, 2022
Immune Responses to Smallpox Vaccination
Completed
- Smallpox Vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
18-42 Year Old Healthy Vaccinia-naïve Subjects Trial in Seoul (MVA BN®, ACAM2000®)
Completed
- 18-42 Year Old Healthy Vaccinia-naïve Subjects
- MVA BN®
- ACAM2000®
-
Seoul, Korea, Republic ofBrian Allgood Army Community Hospital
Nov 18, 2019
Cohort Study of Healthcare Workers Receiving Imvanex®
Completed
- Monkeypox
- Blood draw
-
Blackpool, Lancashire, United Kingdom
- +4 more
Mar 2, 2020
Healthy, Communicable Diseases Trial (Vaccinia Immune Globulin (Human))
Withdrawn
- Healthy
- Communicable Diseases
- Vaccinia Immune Globulin (Human)
- (no location specified)
Oct 28, 2021
HIV, HIV Seronegativity Trial in Saint Louis, Seattle (gp160 Vaccine (Immuno-AG))
Completed
- HIV Infections
- HIV Seronegativity
- gp160 Vaccine (Immuno-AG)
-
Saint Louis, Missouri
- +1 more
Oct 28, 2021
Monkeypox Trial (BNT166a, BNT166c)
Not yet recruiting
- Monkeypox
- BNT166a
- BNT166c
- (no location specified)
Aug 4, 2023
HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)
Active, not recruiting
- HIV-1-infection
- Vaccine
- Placebo
-
Kilifi, Kenya
- +3 more
Jun 21, 2022